Tumor-associated autoantibodies in combination with alpha-fetoprotein for detection of early stage hepatocellular carcinoma - ELISA and cohort data

Tumour associated autoantibodies to recombinant proteins and AFP levels measured via ELISA in the serum of patients with hepatocellular carcinoma, non-cancerous chronic liver disease (NCCLD) and healthy controls. Data for both the discovery and confirmation studies.